Synthesis and stability of four maleimide derivatives of the anticancer drug doxorubicin for the preparation of chemoimmunoconjugates

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 2, 1997, Pages 399-401

  Krüger, Michael ^a   Beyer, Ulrich ^a   Schumacher, Peter ^a   Unger, Clemens ^a   Zahn, Heike ^b   Kratz, Felix ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

^b Clinical Laboratory Limbach   (Germany)

Author keywords

chemoimmunoconjugate; doxorubicin; maleimide derivative; stability

Indexed keywords

AMIDE; CARRIER PROTEIN; DOXORUBICIN DERIVATIVE; HYDRAZONE DERIVATIVE; MALEIMIDE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CONJUGATION; DRUG PROTEIN BINDING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; PH;

EID: 0342460614     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.399     Document Type: Article

References (10)

1. Dorr R. T., Von Hoff D. D., "Cancer Chemotherapy Handbook," 2nd ed. Appleton and Lange, Norwalk, 1994.
2. Carter S. K., J. Natl. Cancer Inst., 55, 1265-1275 (1975).
3. Myers C. E., Chabner B. A., Anthracyclins. In: Chabner B. A., Collins J. M. (eds.). "Cancer Chemotherapy - Principles and Practice," Lippincott, Philadelphia, 1990, pp. 356-381.
4. Means G. E., Feeney R. E., Bioconjugate Chem., 1, 2-12 (1990).
5. Beyer U., Krüger M., Schumacher P., Unger C., Kratz F., Monatshefte der Chemie, Chemical Monthly, (1997), in press.
6. Goldstein J. L., Richard G. W., Brown M. S., Nature (London), 279, 679-685 (1979).
7. Willner D., Trail P. A., Hofstaed S. J., King D. H., Lasch S. J., Braslawsky G. R., Greenfield R. S., Kaneko T., Firestone R. A., Bioconjugate Chem., 4, 521-527 (1993).
8. Mueller B. M., Wrasidlo W. A., Reisfeld R. A., Bioconjugate Chem., 1, 325-330 (1990).
9. Arnone A., Fronza G., Mondelli R., Tetrahedron Lett., 37, 3349-3350 (1976).
10. Tritton T. R., Yee G., Science, 217, 248-250 (1982).